M&A Deal Summary

C. R. Bard Acquires Specialized Health Products Intl

On June 5, 2008, C. R. Bard acquired medical products company Specialized Health Products Intl from Galen Partners for 68M USD

Acquisition Highlights
  • This is C. R. Bard’s 10th transaction in the Medical Products sector.
  • This is C. R. Bard’s 14th largest (disclosed) transaction.
  • This is C. R. Bard’s 12th transaction in the United States.
  • This is C. R. Bard’s 3rd transaction in Utah.

M&A Deal Summary
Date 2008-06-05
Target Specialized Health Products Intl
Sector Medical Products
Buyer(s) C. R. Bard
Sellers(s) Galen Partners
Deal Type Add-on Acquisition
Deal Value 68M USD

Target

Specialized Health Products Intl

Bountiful, Utah, United States
website
Specialized Health Products Intl, Inc.,is a designer, developer, manufacturer and licenser of cost-effective, innovative safety healthcare products.

Search 193,103 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

C. R. Bard

Murray Hill, New Jersey, United States

website

Category Company
Founded 1907
Sector Medical Products
Employees14,900
Revenue 3.7B USD (2016)
DESCRIPTION
Entrance to C. R. Bard's corporate headquarters in Murray Hill, New Jersey.
Entrance to C. R. Bard's corporate headquarters in Murray Hill, New Jersey.

C. R. Bard, Inc. is a multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of vascular, urology, oncology, and surgical specialties. C. R. Bard was formed in 1907 and is based in Murray Hill, New Jersey.

DEAL STATS #
Overall 13 of 23
Sector (Medical Products) 10 of 18
Type (Add-on Acquisition) 13 of 22
State (Utah) 3 of 3
Country (United States) 12 of 22
Year (2008) 1 of 2
Size (of disclosed) 14 of 14
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-03-01 Venetec International

San Diego, California, United States

Venetec International, a manufacturer of the StatLock Line of Catheter Securement Systems.

Buy $166M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-12-07 LifeStent

Irvine, California, United States

LifeStent provides healthcare services. A product family of Edwards Lifesciences Corporation.

Buy $74M

Seller(S) 1

SELLER

Galen Partners

Stamford, Connecticut, United States

Investor Investor Investor Investor Investor

website

Category Growth Capital Firm
Founded 1990
PE ASSETS 1.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Galen Partners is a private equity firm that targets investments in the healthcare industry. Areas within healthcare that Galen will consider include medical devices & technology, specialty pharmaceuticals, and information technology/services. Galen typically invests between $10 and $30 million per transaction in companies with a proprietary product or service that have attained revenues above $10 million. Prospective transactions include growth equity investments, complete buyouts, family business or other recapitalizations, going-private transactions, roll-overs of a portion of existing equity, and management buyouts. Galen Partners was formed in 1990 and is based in Stamford, Connecticut.

DEAL STATS #
Overall 10 of 26
Sector (Medical Products) 1 of 6
Type (Add-on Acquisition) 9 of 22
State (Utah) 2 of 2
Country (United States) 10 of 26
Year (2008) 2 of 3
Size (of disclosed) 9 of 11
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-06-04 Chamberlin Edmonds & Associates

Atlanta, Georgia, United States

Chamberlin Edmonds & Associates is a provider of specialized eligibility determination services to hospitals throughout the U.S. CEA guides uninsured patients through complex application processes to secure government and community reimbursement for uncompensated medical care.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-12-10 Dow Pharmaceutical Sciences

Petaluma, California, United States

Developer, manufacturer and marketer as well as formulator of topical therapies focused on the dermatology market.

Sell $285M
Mergr

Product

Company

Legal